{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:04:59Z","timestamp":1791309899772,"version":"4.3.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,8,15]],"date-time":"2017-08-15T00:00:00Z","timestamp":1502755200000},"content-version":"am","delay-in-days":348,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100009139","name":"DZIF","doi-asserted-by":"publisher","award":["TTU 05.904"],"award-info":[{"award-number":["TTU 05.904"]}],"id":[{"id":"10.13039\/100009139","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.jhep.2016.04.013","type":"journal-article","created":{"date-parts":[[2016,4,30]],"date-time":"2016-04-30T07:14:23Z","timestamp":1462000463000},"page":"483-489","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":211,"title":["First-in-human application of the novel hepatitis B and hepatitis D virus entry inhibitor myrcludex B"],"prefix":"10.1016","volume":"65","author":[{"given":"Antje","family":"Blank","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Markert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Hohmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Carls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"Mikus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten","family":"Lehr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Alexandrov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Haag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Schwab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Urban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter E.","family":"Haefeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2016.04.013_b0005","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2012.02.010","article-title":"EASL clinical practice guidelines: management of chronic hepatitis B virus infection","volume":"57","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.04.013_b0010","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/hep.21513","article-title":"Chronic hepatitis B","volume":"45","author":"Lok","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.04.013_b0015","doi-asserted-by":"crossref","first-page":"284","DOI":"10.4254\/wjh.v6.i5.284","article-title":"Chronic hepatitis B: Advances in treatment","volume":"6","author":"Santantonio","year":"2014","journal-title":"World J Hepatol"},{"key":"10.1016\/j.jhep.2016.04.013_b0020","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/MOG.0b013e32835297ef","article-title":"New advances in chronic hepatitis B","volume":"28","author":"Tujios","year":"2012","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.jhep.2016.04.013_b0025","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2012.01.044","article-title":"Effectiveness of hepatitis B treatment in clinical practice","volume":"142","author":"Scaglione","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2016.04.013_b0030","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/hep.26181","article-title":"The myristoylated preS1-domain of the hepatitis B virus L-protein mediates specific binding to differentiated hepatocytes","volume":"58","author":"Meier","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.04.013_b0035","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/hep.26211","article-title":"Hepatitis B virus hepatotropism is mediated by specific receptor recognition in the liver and not restricted to susceptible hosts","volume":"58","author":"Schieck","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.04.013_b0040","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1128\/JVI.79.3.1613-1622.2005","article-title":"Efficient inhibition of hepatitis B virus infection by acylated peptides derived from the large viral surface protein","volume":"79","author":"Gripon","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2016.04.013_b0045","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.00049","article-title":"Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus","volume":"1","author":"Yan","year":"2012","journal-title":"elife"},{"key":"10.1016\/j.jhep.2016.04.013_b0050","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1128\/JVI.01902-09","article-title":"Fine mapping of pre-S sequence requirements for hepatitis B virus large envelope protein-mediated receptor interaction","volume":"84","author":"Schulze","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2016.04.013_b0055","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1053\/j.gastro.2013.12.024","article-title":"Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes","volume":"146","author":"Ni","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2016.04.013_b0060","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nbt1389","article-title":"Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein","volume":"26","author":"Petersen","year":"2008","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jhep.2016.04.013_b0065","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1053\/j.gastro.2014.04.030","article-title":"Strategies to inhibit entry of HBV and HDV into hepatocytes","volume":"147","author":"Urban","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2016.04.013_b0070","series-title":"Analyse der fr\u00fchen Schritte der Hepatitis B Virus Infektion: Zell-Polarisierung, Differenzierung und Zell-assoziierte Heparansulfat-Proteoglykane als essentielle Faktoren f\u00fcr die Etablierung einer Hepatitis B Virus Infektion","author":"Schulze","year":"2008"},{"key":"10.1016\/j.jhep.2016.04.013_b0075","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.jhep.2012.12.008","article-title":"The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus","volume":"58","author":"Volz","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.04.013_b0080","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jim.2014.03.002","article-title":"Mouse models of hepatitis B and delta virus infection","volume":"410","author":"Dandri","year":"2014","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.jhep.2016.04.013_b0085","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/hep.24758","article-title":"Humanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluation","volume":"55","author":"Lutgehetmann","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.04.013_b0090","unstructured":"Myrcludex B: INVESTIGATOR\u2019S BROCHURE: Myr GmbH; 2014."},{"key":"10.1016\/j.jhep.2016.04.013_b0095","series-title":"Guideline on strategies to identify and mitigate risks for first-in-human clinical trials with investigational medicinal products","year":"2007"},{"key":"10.1016\/j.jhep.2016.04.013_b0100","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1023\/A:1012299115260","article-title":"Ways to fit a PK model with some data below the quantification limit","volume":"28","author":"Beal","year":"2001","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"10.1016\/j.jhep.2016.04.013_b0105","doi-asserted-by":"crossref","first-page":"6815","DOI":"10.1007\/s00216-015-8853-5","article-title":"Quantitative bile acid profiling by liquid chromatography quadrupole time-of-flight mass spectrometry: monitoring hepatitis B therapy by a novel Na-taurocholate cotransporting polypeptide inhibitor","volume":"407","author":"Haag","year":"2015","journal-title":"Anal Bioanal Chem"},{"key":"10.1016\/j.jhep.2016.04.013_b0110","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0140-6736(10)61931-9","article-title":"Hepatitis delta virus","volume":"378","author":"Hughes","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2016.04.013_b0115","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000360948","article-title":"Inhibitors of hepatitis B virus attachment and entry","volume":"57","author":"Lempp","year":"2014","journal-title":"Intervirology"},{"key":"10.1016\/j.jhep.2016.04.013_b0120","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1002\/jps.20125","article-title":"Pharmacokinetic aspects of biotechnology products","volume":"93","author":"Tang","year":"2004","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.jhep.2016.04.013_b0125","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1002\/jps.20178","article-title":"Antibody pharmacokinetics and pharmacodynamics","volume":"93","author":"Lobo","year":"2004","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.jhep.2016.04.013_b0130","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/bdd.2510050309","article-title":"Pharmacokinetics of repeated single oral doses of enalapril maleate (MK-421) in normal volunteers","volume":"5","author":"Till","year":"1984","journal-title":"Biopharm Drug Dispos"},{"key":"10.1016\/j.jhep.2016.04.013_b0135","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1023\/A:1015850911382","article-title":"Dose-dependent pharmacokinetics of the aldose reductase inhibitor imirestat in man","volume":"8","author":"Brazzell","year":"1991","journal-title":"Pharm Res"},{"key":"10.1016\/j.jhep.2016.04.013_b0140","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/jps.2600780706","article-title":"Comparative pharmacokinetics of coumarin anticoagulants. XLIX: Nonlinear tissue distribution of S-warfarin in rats","volume":"78","author":"Cheung","year":"1989","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.jhep.2016.04.013_b0145","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/978-3-642-14541-4_5","article-title":"The role of the sodium-taurocholate cotransporting polypeptide (NTCP) and of the bile salt export pump (BSEP) in physiology and pathophysiology of bile formation","author":"Stieger","year":"2011","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.jhep.2016.04.013_b0150","doi-asserted-by":"crossref","DOI":"10.1002\/hep.27694","article-title":"Impaired uptake of conjugated bile acids and Hepatitis B Virus preS1-binding in Na+-taurocholate cotransporting polypeptide knockout mice","author":"Slijepcevic","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.04.013_b0155","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.jhep.2013.11.022","article-title":"Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor","volume":"60","author":"Nkongolo","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.04.013_b0160","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0379-0738(00)00401-1","article-title":"Organ weight in 684 adult autopsies: new tables for a Caucasoid population","volume":"119","author":"de la Grandmaison","year":"2001","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.jhep.2016.04.013_b0165","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/hep.1840070225","article-title":"Evidence that host size determines liver size: studies in dogs receiving orthotopic liver transplants","volume":"7","author":"Kam","year":"1987","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.04.013_b0170","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.7863\/jum.2003.22.11.1155","article-title":"Factors affecting liver size: a sonographic survey of 2080 subjects","volume":"22","author":"Kratzer","year":"2003","journal-title":"J Ultrasound Med"},{"key":"10.1016\/j.jhep.2016.04.013_b0175","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1002\/hep.27159","article-title":"Binding of hepatitis B virus to its cellular receptor alters the expression profile of genes of bile acid metabolism","volume":"60","author":"Oehler","year":"2014","journal-title":"Hepatology"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827816301453?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827816301453?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:33:03Z","timestamp":1759174383000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827816301453"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0168827816301453"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2016.04.013","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726324642.793535773","asserted-by":"object"}]},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"First-in-human application of the novel hepatitis B and hepatitis D virus entry inhibitor myrcludex B","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2016.04.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}